# Zannan

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zannan

- Industry: Materials
- Headquarters: Shanghai, China
- Latest round: Series E (Jan 5, 2016)
- Investors on record: 9

## About

Established in 2009 and based in Shanghai, China, Zannan is a pharmaceutical company that focuses on the research and development of medicine.

## Funding rounds

- Series E, Jan 5, 2016 — Apex Capital
- Series D, Mar 17, 2015 — Haibang Venture
- Series C, Jan 31, 2014 — China Science & Merchants Capital Management, Sinowisdom, Fang Fund Partners, Zhejiang Fuju Investment Management Co., Ltd., Xinrui Zheshang Investment
- Series B, Mar 1, 2010 — Sinowisdom, PreIPO Capital Partners
- Series A, Dec 29, 2009 — Pivot Capital

## Investors

- Pivot Capital (https://capitalatlas.ai/funds/pivot-capital) — Series A
- Sinowisdom (https://capitalatlas.ai/funds/sinowisdom) — Series B, Series C
- PreIPO Capital Partners (https://capitalatlas.ai/funds/preipo-capital-partners) — Series B
- China Science & Merchants Capital Management (https://capitalatlas.ai/funds/china-science-merchants-capital-management) — Series C
- Fang Fund Partners (https://capitalatlas.ai/funds/fang-fund-partners) — Series C
- Zhejiang Fuju Investment Management Co., Ltd. — Series C
- Xinrui Zheshang Investment — Series C
- Haibang Venture — Series D
- Apex Capital — Series E
